A citation-based method for searching scientific literature

Lynn Macrae, Alicia Navarro de Souza, Carmen G Loiselle, Nora Wong. Hered Cancer Clin Pract 2013
Times Cited: 6







List of co-cited articles
14 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Predictive genetic testing for BRCA1/2 in a UK clinical cohort: three-year follow-up.
C Foster, M Watson, R Eeles, D Eccles, S Ashley, R Davidson, J Mackay, P J Morrison, P Hopwood, D G R Evans. Br J Cancer 2007
54
50


Psychological consequences of predictive genetic testing: a systematic review.
M Broadstock, S Michie, T Marteau. Eur J Hum Genet 2000
238
33

Long-term psychological impact of carrying a BRCA1/2 mutation and prophylactic surgery: a 5-year follow-up study.
Iris van Oostrom, Hanne Meijers-Heijboer, Litanja N Lodder, Hugo J Duivenvoorden, Arthur R van Gool, Caroline Seynaeve, Conny A van der Meer, Jan G M Klijn, Bert N van Geel, Curt W Burger,[...]. J Clin Oncol 2003
193
33

Psychological impact of genetic testing in women from high-risk breast cancer families.
B Meiser, P Butow, M Friedlander, A Barratt, V Schnieden, M Watson, J Brown, K Tucker. Eur J Cancer 2002
93
33

One year follow-up of women opting for presymptomatic testing for BRCA1 and BRCA2: emotional impact of the test outcome and decisions on risk management (surveillance or prophylactic surgery).
Litanja N Lodder, Petra G Frets, R Willem Trijsburg, E Johanna Meijers-Heijboer, Jan G M Klijn, Caroline Seynaeve, Albertus N van Geel, Madeleine M A Tilanus, Carina C M Bartels, Leon C Verhoog,[...]. Breast Cancer Res Treat 2002
128
33

The effect of BRCA gene testing on family relationships: A thematic analysis of qualitative interviews.
Heather A Douglas, Rebekah J Hamilton, Robin E Grubs. J Genet Couns 2009
41
33


Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
33

Psychosocial impact of breast/ovarian (BRCA1/2) cancer-predictive genetic testing in a UK multi-centre clinical cohort.
M Watson, C Foster, R Eeles, D Eccles, S Ashley, R Davidson, J Mackay, P J Morrison, P Hopwood, D G R Evans. Br J Cancer 2004
120
33

'Cancer doesn't have an age': genetic testing and cancer risk management in BRCA1/2 mutation-positive women aged 18-24.
Allison Werner-Lin, Lindsey M Hoskins, Maya H Doyle, Mark H Greene. Health (London) 2012
30
33


Predictive testing of eighteen year olds: counseling challenges.
Clara L Gaff, Elly Lynch, Lesley Spencer. J Genet Couns 2006
22
33

BRCA mutation-negative women from hereditary breast and ovarian cancer families: a qualitative study of the BRCA-negative experience.
Alexis D Bakos, Sadie P Hutson, Jennifer T Loud, June A Peters, Ruthann M Giusti, Mark H Greene. Health Expect 2008
37
33

Looking different, feeling different: women's reactions to risk-reducing breast and ovarian surgery.
Nina Hallowell, Brandi Baylock, Louise Heiniger, Phyllis N Butow, Deepa Patel, Bettina Meiser, Christobel Saunders, Melanie A Price. Fam Cancer 2012
45
16


Predictive genetic testing for hereditary breast and ovarian cancer: psychological distress and illness representations 1 year following disclosure.
E Claes, G Evers-Kiebooms, L Denayer, M Decruyenaere, A Boogaerts, K Philippe, E Legius. J Genet Couns 2005
49
16

Family system characteristics and psychological adjustment to cancer susceptibility genetic testing: a prospective study.
I van Oostrom, H Meijers-Heijboer, H J Duivenvoorden, A H J T Bröcker-Vriends, C J van Asperen, R H Sijmons, C Seynaeve, A R van Gool, J G M Klijn, A Tibben. Clin Genet 2007
55
16

Hereditary cancer risk assessment: essential tools for a better approach.
Israel Gomy, Maria Del Pilar Estevez Diz. Hered Cancer Clin Pract 2013
4
25

Coping with genetic testing for breast cancer susceptibility.
Angela Liegey Dougall, Ashley W Smith, Tamara J Somers, Donna M Posluszny, Wendy S Rubinstein, Andrew Baum. Psychosom Med 2009
12
16

Randomized trial of a shared decision-making intervention consisting of trade-offs and individualized treatment information for BRCA1/2 mutation carriers.
M S van Roosmalen, P F M Stalmeier, L C G Verhoef, J E H M Hoekstra-Weebers, J C Oosterwijk, N Hoogerbrugge, U Moog, W A J van Daal. J Clin Oncol 2004
89
16

The common sense model of self-regulation and psychological adjustment to predictive genetic testing: a prospective study.
Iris van Oostrom, Hanne Meijers-Heijboer, Hugo J Duivenvoorden, Annette H J T Bröcker-Vriends, Christi J van Asperen, Rolf H Sijmons, Caroline Seynaeve, Arthur R Van Gool, Jan G M Klijn, Aad Tibben. Psychooncology 2007
34
16

Psychological impact of genetic testing for hereditary non-polyposis colorectal cancer.
B Meiser, V Collins, R Warren, C Gaff, D J B St John, M-A Young, K Harrop, J Brown, J Halliday. Clin Genet 2004
61
16

Psychological support needs for women at high genetic risk of breast cancer: some preliminary indicators.
P Hopwood, F Keeling, A Long, C Pool, G Evans, A Howell. Psychooncology 1998
89
16

What I wish I'd known before surgery: BRCA carriers' perspectives after bilateral salipingo-oophorectomy.
Danielle Campfield Bonadies, Anne Moyer, Ellen T Matloff. Fam Cancer 2011
39
16


Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.
Timothy R Rebbeck, Henry T Lynch, Susan L Neuhausen, Steven A Narod, Laura Van't Veer, Judy E Garber, Gareth Evans, Claudine Isaacs, Mary B Daly, Ellen Matloff,[...]. N Engl J Med 2002
16

Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.
Noah D Kauff, Jaya M Satagopan, Mark E Robson, Lauren Scheuer, Martee Hensley, Clifford A Hudis, Nathan A Ellis, Jeff Boyd, Patrick I Borgen, Richard R Barakat,[...]. N Engl J Med 2002
868
16

Feasibility evaluation of an online tool to guide decisions for BRCA1/2 mutation carriers.
Elizabeth A Schackmann, Diego F Munoz, Meredith A Mills, Sylvia K Plevritis, Allison W Kurian. Fam Cancer 2013
8
16

Randomised trial of a decision aid and its timing for women being tested for a BRCA1/2 mutation.
M S van Roosmalen, P F M Stalmeier, L C G Verhoef, J E H M Hoekstra-Weebers, J C Oosterwijk, N Hoogerbrugge, U Moog, W A J van Daal. Br J Cancer 2004
55
16

Health behaviors and psychological distress in women initiating BRCA1/2 genetic testing: comparison with control population.
Michel Dorval, Karine Bouchard, Elizabeth Maunsell, Marie Plante, Jocelyne Chiquette, Stéphanie Camden, Michel J Dugas, Jacques Simard. J Genet Couns 2008
25
16

Hopefulness predicts resilience after hereditary colorectal cancer genetic testing: a prospective outcome trajectories study.
Samuel M Y Ho, Judy W C Ho, George A Bonanno, Annie T W Chu, Emily M S Chan. BMC Cancer 2010
43
16

Impact of BRCA1/2 testing and disclosure of a positive test result on women affected and unaffected with breast or ovarian cancer.
Mariëlle S van Roosmalen, P F M Stalmeier, L C G Verhoef, J E H M Hoekstra-Weebers, J C Oosterwijk, N Hoogerbrugge, U Moog, W A J van Daal. Am J Med Genet A 2004
48
16

Risks of less common cancers in proven mutation carriers with lynch syndrome.
Christoph Engel, Markus Loeffler, Verena Steinke, Nils Rahner, Elke Holinski-Feder, Wolfgang Dietmaier, Hans K Schackert, Heike Goergens, Magnus von Knebel Doeberitz, Timm O Goecke,[...]. J Clin Oncol 2012
176
16

Passive coping and psychological distress in women adhering to regular breast cancer surveillance.
K Pieterse, S van Dooren, C Seynaeve, C C M Bartels, A J Rijnsburger, H J de Koning, J G M Klijn, T van Elderen, A Tibben, H J Duivenvoorden. Psychooncology 2007
22
16


Variants of unknown significance in BRCA testing: impact on risk perception, worry, prevention and counseling.
S Richter, I Haroun, T C Graham, A Eisen, A Kiss, E Warner. Ann Oncol 2013
60
16


The impact of predictive genetic testing for hereditary nonpolyposis colorectal cancer: three years after testing.
Veronica R Collins, Bettina Meiser, Obioha C Ukoumunne, Clara Gaff, D James St John, Jane L Halliday. Genet Med 2007
55
16

Clinical utility gene card for: Lynch syndrome (MLH1, MSH2, MSH6, PMS2).
Nils Rahner, Verena Steinke, Brigitte Schlegelberger, Sylviane Olschwang, François Eisinger, Pierre Hutter. Eur J Hum Genet 2010
5
20

Women's constructions of the 'right time' to consider decisions about risk-reducing mastectomy and risk-reducing oophorectomy.
A Fuchsia Howard, Joan L Bottorff, Lynda G Balneaves, Charmaine Kim-Sing. BMC Womens Health 2010
21
16

The impact of prophylactic salpingo-oophorectomy on quality of life and psychological distress in women with a BRCA mutation.
Amy Finch, Kelly A Metcalfe, Jaclyn Chiang, Lorraine Elit, John McLaughlin, Caitlin Springate, Mary Jane Esplen, Rochelle Demsky, Joan Murphy, Barry Rosen,[...]. Psychooncology 2013
59
16

Psychological impact of genetic testing for hereditary nonpolyposis colorectal cancer.
Ellen R Gritz, Susan K Peterson, Sally W Vernon, Salma K Marani, Walter F Baile, Beatty G Watts, Christopher I Amos, Marsha L Frazier, Patrick M Lynch. J Clin Oncol 2005
86
16

Variation in rates of uptake of preventive options by Canadian women carrying the BRCA1 or BRCA2 genetic mutation.
Kelly A Metcalfe, Parviz Ghadirian, Barry Rosen, William Foulkes, Charmaine Kim-Sing, Andrea Eisen, Peter Ainsworth, Doug Horsman, Christine Maugard, Diane Provencher,[...]. Open Med 2007
35
16

Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian cancer.
Joanna B Madalinska, Judith Hollenstein, Eveline Bleiker, Marc van Beurden, Heiddis B Valdimarsdottir, Leon F Massuger, Katja N Gaarenstroom, Marian J E Mourits, René H M Verheijen, Eleonora B L van Dorst,[...]. J Clin Oncol 2005
167
16

Applying a cognitive behavioral model of health anxiety in a cancer genetics service.
Katharine A Rimes, Paul M Salkovskis, Linda Jones, Anneke M Lucassen. Health Psychol 2006
15
16

Colon cancer screening practices after genetic counseling and testing for hereditary nonpolyposis colorectal cancer.
Donald W Hadley, Jean F Jenkins, Eileen Dimond, Maria de Carvalho, Ilan Kirsch, Christina G S Palmer. J Clin Oncol 2004
110
16

Psychological impact of receiving a BRCA1/BRCA2 test result.
L Lodder, P G Frets, R W Trijsburg, E J Meijers-Heijboer, J G Klijn, H J Duivenvoorden, A Tibben, A Wagner, C A van der Meer, A M van den Ouweland,[...]. Am J Med Genet 2001
114
16

Factors associated with an individual's decision to withdraw from genetic testing for breast and ovarian cancer susceptibility: implications for counseling.
Béatrice Godard, Annabelle Pratte, Martine Dumont, Adèle Simard-Lebrun, Jacques Simard. Genet Test 2007
33
16

BRCA1/2 genetic testing uptake and psychosocial outcomes in men.
Kristi D Graves, Rhoda Gatammah, Beth N Peshkin, Ayelet Krieger, Christy Gell, Heiddis B Valdimarsdottir, Marc D Schwartz. Fam Cancer 2011
18
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.